AMF Tjanstepension AB Increases Stock Holdings in HCA Healthcare, Inc. $HCA

AMF Tjanstepension AB increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 125,586 shares of the company’s stock after purchasing an additional 20,595 shares during the quarter. AMF Tjanstepension AB owned 0.05% of HCA Healthcare worth $48,120,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Brighton Jones LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at about $1,021,000. Merit Financial Group LLC boosted its stake in shares of HCA Healthcare by 109.9% in the first quarter. Merit Financial Group LLC now owns 3,293 shares of the company’s stock valued at $1,138,000 after buying an additional 1,724 shares in the last quarter. RFG Advisory LLC purchased a new position in HCA Healthcare in the first quarter worth $204,000. Ullmann Wealth Partners Group LLC boosted its position in shares of HCA Healthcare by 1.3% during the 1st quarter. Ullmann Wealth Partners Group LLC now owns 6,890 shares of the company’s stock worth $2,381,000 after purchasing an additional 88 shares in the last quarter. Finally, Curat Global LLC purchased a new position in shares of HCA Healthcare in the 1st quarter valued at about $242,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Bank of America upped their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 10th. Wells Fargo & Company dropped their price objective on HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating for the company in a research note on Thursday, August 14th. Barclays boosted their target price on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, July 16th. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday, September 27th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $407.75.

HCA Healthcare Stock Up 0.7%

HCA opened at $429.52 on Friday. The firm has a market cap of $100.50 billion, a P/E ratio of 18.05, a PEG ratio of 1.34 and a beta of 1.40. The business’s fifty day simple moving average is $397.53 and its 200 day simple moving average is $372.39. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $432.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.